Prof Dr .Meinolf Suttorp | Medicine and Dentistry| Lifetime achievement Award

Senior Prof. em. Dr. med. Meinolf Suttorp is a renowned expert in pediatric hematology and oncology, particularly known for his groundbreaking work in pediatric chronic myeloid leukemia (CML). With a career spanning over four decades, Dr. Suttorp has significantly contributed to advancing CML treatment, including the optimization of therapeutic strategies and molecular characterization of key chromosomal translocations. He has held influential positions, including chairman of the CML-Working Party of the International BFM Study Group, and is an active member of multiple international scientific societies. Dr. Suttorp has authored numerous peer-reviewed articles and continues to mentor young researchers while leading clinical trials. His global impact extends through his involvement with the International CML Foundation, advocating for better pediatric cancer care in emerging regions. His work remains pivotal in shaping the future of pediatric oncology, making him a distinguished figure in the medical community.

Senior Prof. em. Dr. med. Meinolf Suttorp has a robust academic background that laid the foundation for his distinguished career in pediatric hematology and oncology. He began his academic journey studying Chemistry at the University of Münster, Germany, from 1973 to 1978, where he specialized in Applied Organic Chemistry and earned his Diploma in Chemistry in February 1979. Driven by a passion for medical science, he pursued further studies in Human Medicine at the University of Kiel, Germany, from 1978 to 1984. He obtained his Doctor of Medicine degree in December 1984, followed by a medical license the same year. His postdoctoral qualifications include achieving Assistant Professor status (“Privatdozent”) in 1995 and becoming a full Professor of Pediatric Hematology and Oncology in 2001 at the Technical University of Dresden. Over his academic career, Dr. Suttorp has combined his expertise in chemistry and medicine, shaping his profound contributions to pediatric hematology and oncology research and treatment.

Senior Prof. em. Dr. med. Meinolf Suttorp has had an extensive and distinguished career in pediatric hematology and oncology, particularly focusing on pediatric chronic myeloid leukemia (CML). With over four decades of professional experience, he began his career studying chemistry and medicine at the Universities of Münster and Kiel, later obtaining his Doctor of Medicine and becoming a licensed physician in 1984. His research and clinical journey has been marked by key roles, including Assistant Professor at the University of Kiel and Head of Pediatric Hematology and Oncology at the Technical University of Dresden, where he served from 2001 to 2018. Dr. Suttorp’s work has been pivotal in developing new treatment strategies for CML in children and understanding the molecular basis of the disease. His leadership in international collaborations, including chairing the CML-Working Party of the International BFM Study Group, has contributed to advancing global pediatric oncology research.

Senior Prof. em. Dr. med. Meinolf Suttorp demonstrates exemplary research skills, particularly in the field of pediatric hematology and oncology. His work is characterized by a deep understanding of molecular biology, with a focus on chronic myeloid leukemia (CML) in children. Dr. Suttorp has played a pivotal role in advancing knowledge of the molecular mechanisms behind CML, notably through his research on the chromosomal translocation t(9;22). His ability to design and execute large-scale clinical trials, such as those conducted under the International BFM Study Group, reflects his expertise in both clinical and translational research. Dr. Suttorp’s collaboration with international researchers and his leadership in multidisciplinary teams highlight his skills in fostering cooperation and sharing knowledge. Additionally, his contributions to academic literature, with numerous high-impact publications, demonstrate his strong analytical skills, attention to detail, and commitment to advancing pediatric oncology research. His ongoing mentorship of young researchers further cements his reputation as a research leader.

Senior Prof. em. Dr. med. Meinolf Suttorp has received numerous accolades throughout his illustrious career in pediatric hematology and oncology. He has been honored for his pioneering work in pediatric chronic myeloid leukemia (CML), particularly for advancing research on molecular characterization and improving treatment protocols. As a recognized leader in the field, Dr. Suttorp has received prestigious fellowships from the Deutsche Forschungsgemeinschaft (DFG) early in his career, supporting his groundbreaking research. His contributions to international collaboration, notably as chairman of the CML-Working Party of the International BFM Study Group, have earned him widespread recognition. Additionally, his role as a member of the Advisory Board of the International CML Foundation (iCMLf) and Steering Committee of the German CML Alliance further highlights his influence in shaping global pediatric CML treatment standards. His extensive publication record and service as a reviewer for major scientific journals and organizations have also been acknowledged with several academic and research awards.